Pictet Asset Management (Switzerland)’s Supernus Pharmaceuticals SUPN Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio SUPN Stock Details SUPN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$23.4M	Buy
2023 Q1	$22.1M	Buy
2022 Q4	$7.94M	Buy
2022 Q3	$5.55M	Buy
2022 Q2	$3.73M	Buy
2022 Q1	$3.68M	Sell
2021 Q4	$3.65M	Sell
2021 Q3	$4.28M	Buy